The first two successful laryngotracheal transplants have been completed in Russia, using stem cells grown from the patients’ bone marrow. The cells were grown in a specially-designed bioreactor made by Harvard Bioscience, Inc., a Massachusetts-based company. The announcement was made by Harvard Bioscience.
The transplants, which required more than six months of preparation, were performed on the first two patients enrolled in an ongoing clinical trial at Krasnodar Regional Hospital in Russia. The procedures are the result of a global collaboration involving organizations in the U.S., Sweden, Russia, Germany and Italy. The patients were treated as part of a $4.8 million Russian government grant designed to foster international collaboration.
Both of the patients are under age 35 and suffered severe damage to their tracheas due to car accidents and subsequent comas they sustained.Both patients were able to breathe and speak normally after the procedure.
Research, in additional to finding stem cell cures for conditions, such as ALS, diabetes, heart disease and MS, is alsoexploring the use of stem cells to grow various tissues for use in transplants,but widespread treatment is still in the near-future.Some conditions, such as joint, tendon and muscle injuries, are treatable now with stem cells.
Dr Dennis Lox has been sucessfully preforming stem cell therapy for several years. Dr. Lox is located in the Tampa bay area in Clearwater, Florida
Information contained in this blog is intended for educational purposes only and not for medical diagnosis or treatment. If you have a medical concern or issue, please consult with your physician.